bpc 157 legal status fda approval Peptides like BPC-157 and TB-500 are blowing up online for injury recovery, but they’re not FDA-approved and they’re in a gray area. The end of July, an advisory committee meets to weigh in The FDA Is About to
Description
Over 68 weeks, those in the semaglutide group lost an average of 14.9 percent of their baseline body weight, versus just 2.4 percent in the control group, with the treatment effect yielding a 12.4 percent greater reduction in body weight compared to placebo

The preclinical data is real and scientifically interesting

I committed to an 8-week protocol and hoped for the best

Archived from the original on October 30, 2017
